HIV Management and Research
Dr. Bedimo studies strategies for optimally managing drug-resistance in people infected with HIV, analyzing their metabolic abnormalities, and studying the effects of HCV co-infection.
Meet the Principal Investigator
Roger Bedimo, M.D.
Professor of Internal Medicine
Division of Infectious Diseases & Geographic Medicine
Service Chief of Infectious Diseases, North Texas VA
Research Overview
Dr. Bedimo studies strategies for optimally managing drug-resistant HIV patients, analyzing metabolic abnormalities in HIV patients, and studying the effects of HCV co-infection.
Presently, the latest cutting-edge antiviral therapies are available through expanded access programs, and interested patients are offered the opportunity to join in national multicenter clinical trials and novel pilot studies being performed locally. Research is an important part of HIV care, both to learn more about how to treat this infection, and to bring the latest advances to our patients.
Current studies
- Novel therapies for patients with drug-resistant HIV
- Studies of lipid risk factors, prevention and management of dyslipidemia, lipodystrophy, and bone mineral loss among HIV-infected patients
- Analysis of the trends of Non-AIDS-defining malignancies among HIV-infected patients comparing incidences pre-and post Highly Active Anti-retroviral Therapy (HAART), and analysis of factors associated with increased risk
- Studies of simplified combination therapy and novel immune-based therapy
- Laboratory-based research to understand the mechanisms of dyslipidemia among HIV and HIV/HCV co-infected patients
Featured Publications
Statin use and medically attended acute respiratory illness among influenza vaccine recipients.
Cutrell JB, Drechsler H, Bedimo R, Alvarez CA, Mansi IA, 2019 Sep VaccineIntegrated stepped alcohol treatment for patients with HIV and liver disease: A randomized trial.
Edelman EJ, Maisto SA, Hansen NB, Cutter CJ, Dziura J, Deng Y, Fiellin LE, O'Connor PG, Bedimo R, Gibert CL, Marconi VC, Rimland D, Rodriguez-Barradas MC, Simberkoff MS, Tate JP, Justice AC, Bryant KJ, Fiellin DA, 2019 Nov J Subst Abuse Treat 106 97-106Short-term outcomes for lung cancer resection surgery in HIV infection.
Sigel KM, Stone K, Wisnivesky JP, Park LS, Kong CY, Silverberg MJ, Brown S, Goetz M, Rodriguez-Barradas MC, Gibert C, Shebl F, Bedimo R, Wadia R, King J, Crothers K, 2019 Jul AIDS 8 33 1353-1360Microvascular Disease, Peripheral Artery Disease and Amputation.
Beckman JA, Duncan MS, Damrauer SM, Wells QS, Barnett JV, Wasserman DH, Bedimo RJ, Butt AA, Marconi VC, Sico JJ, Tindle HA, Bonaca MP, Aday AW, Freiberg MS, 2019 Jul CirculationIncreased Fragility Fracture Rates in Older Men with Osteomyelitis.
Hsieh E, Shiau S, Nolan O, Gibert CL, Bedimo RJ, Rodriguez-Barradas MC, Justice AC, Womack JA, Yin MT 2019 Feb Clin. Infect. Dis.HIV Infection, Cardiovascular Disease Risk Factor Profile, and Risk for Acute Myocardial Infarction.
Paisible AL, Chang CC, So-Armah KA, Butt AA, Leaf DA, Budoff M, Rimland D, Bedimo R, Goetz MB, Rodriguez-Barradas MC, Crane HM, Gibert CL, Brown ST, Tindle HA, Warner AL, Alcorn C, Skanderson M, Justice AC, Freiberg MS 2015 Feb J. Acquir. Immune Defic. Syndr. 2 68 209-16CD8 (+) T-Cells Count in Acute Myocardial Infarction in HIV Disease in a Predominantly Male Cohort.
Badejo OA, Chang CC, So-Armah KA, Tracy RP, Baker JV, Rimland D, Butt AA, Gordon AJ, Rinaldo CR, Kraemer K, Samet JH, Tindle HA, Goetz MB, Rodriguez-Barradas MC, Bedimo R, Gibert CL, Leaf DA, Kuller LH, Deeks SG, Justice AC, Freiberg MS 2015 Biomed Res Int 2015 246870CD4 counts and mortality in virologically suppressed US veterans.
Drechsler H, Zhang S, Holodniy M, Bedimo R 2014 Mar-Apr J Int Assoc Provid AIDS Care 2 13 120-6Adverse outcome analyses of observational data: assessing cardiovascular risk in HIV disease.
Triant VA, Josephson F, Rochester CG, Althoff KN, Marcus K, Munk R, Cooper C, D'Agostino RB, Costagliola D, Sabin CA, Williams PL, Hughes S, Post WS, Chandra-Strobos N, Guaraldi G, Young SS, Obenchain R, Bedimo R, Miller V, Strobos J 2012 Feb Clin. Infect. Dis. 3 54 408-13Contact Us
Roger Bedimo, M.D., M.S., FACP
Professor of Internal Medicine
Chief, Infectious Disease Section
VA North Texas Health Care System
Mailing Address
VAMC Office Phone: (214) 857-0397
UTSW Office Phone: (214) 648-9914
Pager: 214-759-3154